Sign in
SNSE Stock Price, Chart, Stats & News
Sensei Biotherapeutics, Inc.
Save
18.59M
Market cap
–
Current P/E
–
Forward P/E
SNSE chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 4.25% |
Operating margin | 508.23% |
Pretax margin | 497.61% |
Net margin | 497.61% |
Effective tax rate | – |
ROA | -87.50% |
ROE | -80.00% |
D/E | 0.09x |
Interest coverage ratio | -535.96x |
SNSE valuation
P/E | – |
P/S | -7.20x |
P/B | 1.52x |
P/CF | -1.56x |
P/FCF | -1.56x |
P/OCF | -1.56x |
PEG | 0.02x |
EV multiple | -1.82x |
About
Sensei Biotherapeutics, Inc. (SNSE) is a biopharmaceutical firm dedicated to discovering and advancing immunotherapies, primarily for cancer treatment. The company's innovative approaches include its proprietary ImmunoPhage platform. This immunotherapy leverages bacteriophages to orchestrate a precise and robust innate and adaptive immune response.
Similar securities
Based on sector and market capitalization
Report issue